Recovery pathway
Repair
BPC-157 & TB-500
Laboratory verification
Nothing unverified is published
Every compound is prepared to a documented standard. Independent certificates of analysis are published here per batch as they are verified under Nuragen's own governance, we do not reuse another brand's certificates or purity figures.
Certificate of analysis · per batch · on request
Verification-led release
Repair pairs two of the most widely studied tissue-repair peptides, BPC-157 and TB-500, as a single focused reference set. It is a research-use-only material intended for laboratory investigation of the recovery pathway.
How it is studied
In the research literature, BPC-157 and TB-500 are examined for their roles in tissue-repair and regenerative signalling. BPC-157 is studied in the context of angiogenesis and the modulation of growth-factor pathways, while TB-500 is investigated for its association with actin regulation and cell migration. Repair presents the two together so researchers can reference a recovery-pathway pairing in a single set. All work described here is laboratory-based and non-clinical.
The components and the pathway
BPC-157 is a synthetic peptide sequence derived from a protein fragment identified in gastric juice, studied for its interaction with vascular and repair-associated signalling. TB-500 is a synthetic form of a thymosin beta-4 fragment, researched for its role in cytoskeletal dynamics and cellular movement. Together they sit within what is broadly described as the recovery pathway. The pairing reflects how the two are frequently discussed side by side in the research literature, each thought to act on complementary aspects of tissue-repair signalling.
How it sits in a responsible research programme
Repair is supplied as a defined pair to keep laboratory workflows clear and documented. It is intended for controlled, in-vitro and preclinical research settings where handling, records and objectives are established in advance. Presenting the two peptides as a focused set supports structured comparison and repeatable methodology. Nothing here is offered for human or animal use.
Composition
| Component | CAS | Purity |
|---|---|---|
| BPC-157 | 137525-51-0 | Pending |
| TB-500 | 77591-33-4 | Pending |
| Type | Lyophilised powder |
|---|---|
| Presentation | Lyophilised powder |
| Appearance | White lyophilised powder |
| Storage | Store at 2-8°C, protected from light. |
| Dispatch | Delivered within 72 hours across the UK. |
Handling should follow standard laboratory practice and your own institutional protocols. No dosing, administration or medical guidance is provided.
Repair is a focused pair of two tissue-repair peptides, BPC-157 and TB-500, associated with the recovery pathway in the research literature. It is supplied strictly for research use only. It is not a medicine and is not intended for human or animal use, diagnosis or any form of administration.
As a general laboratory practice, research peptides of this type are typically stored refrigerated at 2-8C and protected from light, with handling carried out under appropriate controlled conditions. Follow your own institutional protocols and any documentation accompanying the material, and treat all handling as part of a documented research workflow.
No. We provide factual, process-based information about what these compounds are and the pathways they are studied to act on. We do not provide dosing, administration instructions, protocols or medical advice of any kind, and nothing here should be interpreted as such.
The two are frequently discussed side by side in the research literature because each is thought to act on complementary aspects of tissue-repair signalling. Presenting them as a defined pair lets researchers reference a recovery-pathway pairing within a single, clearly documented set.
In context
Evidence before action
The recovery pathway is an area of active investigation, and much of what is understood about BPC-157 and TB-500 comes from preclinical and mechanistic studies rather than settled conclusions. A responsible programme reads the primary literature closely, distinguishes what a compound is studied to do from what remains unproven, and documents each step. We describe pathways and research context, not outcomes. This is what accountable science looks like: measured interpretation, careful records, and no claim that runs ahead of the evidence.

